Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.

The Ratio of Atypical Ductal Hyperplasia Foci to Core Numbers in Needle Biopsy: A Practical Index Predicting Breast Cancer in Subsequent Excision

´ëÇѺ´¸®ÇÐȸÁö 2012³â 46±Ç 1È£ p.15 ~ 21
ÀÌÁ¤ÁÖ, ÀÌÈñÁø, °­ÁØ, Á¶Á¤Çö, °ø°æ¿±,
¼Ò¼Ó »ó¼¼Á¤º¸
ÀÌÁ¤ÁÖ ( Lee Jeong-Ju ) 
University of Ulsan College of Medicine Department of Pathology

ÀÌÈñÁø ( Lee Hee-Jin ) 
University of Ulsan College of Medicine Department of Pathology
°­ÁØ ( Kang Jun ) 
University of Ulsan College of Medicine Department of Pathology
Á¶Á¤Çö ( Jo Jeong-Hyeon ) 
University of Ulsan College of Medicine Department of Pathology
°ø°æ¿± ( Gong Gyung-Yub ) 
University of Ulsan College of Medicine Department of Pathology

Abstract


Background: Although core needle biopsy (CNB) is considered to be the standard technique for histological diagnosis of breast lesions, it is less reliable for diagnosing atypical ductal hyperplasia (ADH). We therefore assessed the characteristics of CNB-diagnosed ADH that are more likely to be associated with more advanced lesions on subsequent surgical excision.

Methods: We retrospectively examined 239 consecutive CNBs, 127 of which were diagnosed as ADH following surgical excision, performed at Asan Medical Center between 1995 and 2010. Archival slides were analyzed for the number of cores per specimen, the number of ADH foci, and the ratio of ADH foci to number of cores (FC ratio).

Results: We found that ADH foci in 3 or more cores (p=0.003) and the presence of ADH in 3 or more foci (p=0.002) were correlated with malignancy following excision lesion. Moreover, an FC>1.1 was significantly associated with malignancy in the subsequent excision (p=0.000).

Conclusions: Including the number of ADH foci, the number of cores involved according to ADH, FC ratio, and histologic type in a pathology report of CNB may help in making clinical decisions about surgical excision.

Å°¿öµå

Atypical ductal hyperplasia; Core needle biopsy; Predictive pathologic factor

¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸

  

µîÀçÀú³Î Á¤º¸

KCI
KoreaMed
KAMS